MarketsandMarkets analysis says that a Potential Opportunity Worth Bn is opePosted by snehal shaha on January 17th, 2022 As Genome Sequencing heads to 0 Direct-to-Consumer, a potential opportunity worth Bn is expected to open up, leading to a million terabytes of genome data by 2025. The genome sequencing market will reach Bn by 2026, further intensified by COVID-19, and oncology and rare disease diagnostics coupled with pan genome studies. Adjacent markets of data storage, high performance computing (HPC), lab automation, and AI are anticipated to see unlocking of a further Bn. Download PDF Brochure: https://www.marketsandmarkets.com/practices/pdfdownload.asp According to MarketsandMarkets analysis, Bn of potential opportunity is opening up as genome sequencing heads to 0 direct-to-consumer, which was one of the most talked-about trends in 2021. MarketsandMarkets is focused on high-growth, niche markets, such as AI in genomics, spatial genomics & transcriptomics, liquid biopsy, single-cell analysis, and related markets, providing a comprehensive understanding of the entire genomics ecosystem through the World’s First Market Intelligence Cloud, ‘KnowledgeStore’. It helps find blind spots in clients’ revenue decisions because of interconnections and unknowns that impacting clients and their client’s clients. For more details, please visit: https://www.marketsandmarkets.com/practices/genomics-new.asp Like it? Share it!More by this author |